We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current LXRX market cap is 131.76M. The company's latest EPS is USD -0.5544 and P/E is -0.67.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 702k | 1.13M | 1.65M | 1.75M | 26.55M |
| Operating Income | -46.74M | -45.33M | -55.35M | -63.69M | -32.74M |
| Net Income | -49.76M | -48.4M | -53.43M | -64.81M | -33.77M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 24M | 298k | 139k | 1.2M | 31.08M |
| Operating Income | -180.39M | -87.09M | -100.76M | -171.75M | -197.12M |
| Net Income | -58.57M | -87.76M | -101.94M | -177.12M | -200.4M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 229.43M | 417.22M | 373.36M | 321.12M | 298.42M |
| Total Liabilities | 136.32M | 128.35M | 133.38M | 142.61M | 152.47M |
| Total Equity | 93.11M | 288.87M | 239.98M | 178.51M | 145.95M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 203.79M | 136.91M | 194.3M | 229.43M | 298.42M |
| Total Liabilities | 47.42M | 23.31M | 77.18M | 136.32M | 152.47M |
| Total Equity | 156.37M | 113.6M | 117.12M | 93.11M | 145.95M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -161.9M | -55.13M | -103.67M | -157.29M | -178.78M |
| Investing | -49.94M | -110.22M | -122.55M | -69.08M | -15.38M |
| Financing | 187.96M | 239.38M | 239.37M | 238.45M | 238.35M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -142.97M | -87.02M | -88.85M | -161.9M | -178.78M |
| Investing | 380.76M | 2.11M | -71.08M | -49.94M | -15.38M |
| Financing | -147.64M | 22.71M | 142.21M | 187.96M | 238.35M |
| Market Cap | 131.76M |
| Price to Earnings Ratio | -0.67 |
| Price to Sales Ratio | 4.3 |
| Price to Cash Ratio | 2.01 |
| Price to Book Ratio | 0.92 |
| Dividend Yield | - |
| Shares Outstanding | 361.49M |
| Average Volume (1 week) | 5.94M |
| Average Volume (1 Month) | 9.57M |
| 52 Week Change | -85.98% |
| 52 Week High | 2.60 |
| 52 Week Low | 0.2836 |
| Spread (Intraday) | 0 (0.08%) |
| Company Name | Lexicon Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.lexpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
